Throughout the year, our Editors may issue a Call for Papers for a special collection of articles for a themed issue or themed section of the journal. Below you’ll find links to the current Call for Papers for Value in Health.
Call for Papers:
Today nearly 30% of the world’s data is generated by the healthcare industry. These data are typically collected for administrative purposes and are often proprietary. While big healthcare data has the potential to improve patient outcomes and ultimately reduce healthcare costs, much of this data is siloed in disparate systems and platforms, making it difficult to access by researchers in both the HEOR and health services research fields.
In this special anniversary issue of Value in Health, the Editors are seeking papers that address the complexities of finding the right balance between data privacy and access to data for health services research.
This special anniversary issue is tentatively scheduled to appear in the May 2023 issue of Value in Health. Submissions received before September 15, 2022 have the best chance of inclusion in this special anniversary issue.
Integration of relevant effectiveness and safety outcomes in economic evaluation of drugs, medical devices, and vaccines is required to aid efficient healthcare decisions on coverage and to support price negotiation for healthcare interventions. However, in the field of health economic evaluation, there are no standardized methods or practices related to the inclusion of adverse events (AEs) in studies. The aim of this themed section is to publish a collection of papers that focus on key questions related to the inclusion of AEs in economic evaluation of health technologies to create a body of work aimed at moving the field forward.
Authors interested in submitting an article for this themed section should submit a brief description (no more than 500 words) of their proposed study to the editors via our online portal by August 1, 2022, with an anticipated submission date for the full manuscript by September 15, 2022.
Increases in drug prices and drug spending are of concern to health systems worldwide. This has naturally driven policy interest and discussion around drug pricing and the need to balance affordability with sustaining innovation. This themed section aims to present and discuss the results from original research or case studies that estimate the impact on health systems in different countries of alternative lifecycle pricing strategies applied to prescription drugs.
Authors interested in submitting an article for this themed section should submit a brief description (no more than 500 words) of their proposed study to the editors via our online portal by November 30, 2021, with an anticipated submission date for the full manuscript by April 30, 2022. An indication of the level of interest in the proposed study will be sent to the authors by December 31, 2021.Download Fact Sheet Submit Now
Systematic literature reviews are an essential component for obtaining data inputs or assessing the impact of health technologies on clinical, economic, or health-related quality of life. Recognizing the inherent usefulness of these types of studies, the Editors of Value in Health are issuing an open Call for Papers for systematic literature reviews on a wide array of topics that seek to inform healthcare decision making.
Submissions received before September 1, 2021 will have the best chance of being published in Value in Health in 2022. Final decisions regarding ultimate acceptance rest solely with the Editors.
Authors should submit manuscripts through the journal’s web-based tracking system and be sure to classify their submissions as Systematic Literature Reviews.